NRX Pharmaceuticals NRXP SEC Filings

NASDAQ NRXP
$3.40 +0.03 (+0.89%)
As of: Sep 10, 2026 · 3:59 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document NRX Pharmaceuticals, Inc. (NRXP) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index